Paul Dicpinigaitis, MD
Adult Reconstructive Orthopaedic Surgery · New Hyde Park, NYNPI 1477530111
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (49.3%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Think Surgical, Inc. at 57.1% of the total. Reporting peaked in 2019 at $13,332 and has fallen 95.3% since, to $631 in 2025.
Across 71 payments — averaging $228.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Think Surgical, Inc.$9K
- Stryker$2K
- Encore Medical, LP$2K
- Zimmer Biomet$987
- Medical Device Business Services, Inc.$742
- Exactech, Inc.$293
- plus $782 from 5 others
What the payments were for
- Consulting fees$8,00049%
- Travel & lodging$4,97131%
- Food & beverage$3,25620%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Think Surgical, Inc. | 5 | $9,262 |
| Stryker | 21 | $2,302 |
| Encore Medical, LP | 7 | $1,859 |
| Zimmer Biomet | 16 | $987 |
| Medical Device Business Services, Inc. | 8 | $742 |
| Exactech, Inc. | 1 | $293 |
| Johnson & Johnson | 4 | $259 |
| Heron Therapeutics, Inc. | 2 | $241 |
| Smith+Nephew | 1 | $148 |
| Ferring Pharmaceuticals Inc. | 5 | $99 |
| Osteomed LLC | 1 | $35 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Tsolution One Surgical System$9,210
- MAKO$1,589
- DJO Surgical Linear Hip System$1,129
- ACTIS$579
- DJO Surgical TaperFill Hip System$542
- Taperloc$470
- EQUINOXE$293
- ROSA$293
- DJO SURGICAL$255
- Zynrelef$218
- TRIATHLON$150
- Journey II BCS$148
- VISIONAIRE Cutting Guides$148
- ATTUNE$112
How this compares
$16,227 in reported general payments places this provider in the 55th percentile of 85 adult reconstructive orthopaedic surgery providers in New York.
See all adult reconstructive orthopaedic surgery providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 20 | $292 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 18 | $169 |
| Tramadol Hcl | 36 | $131 |
| Meloxicam | 14 | $44 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in New Hyde Park
- Seth JerabekNew York$7.1M
- Jose RodriguezNew York$3.4M
- Friedrich BoettnerNew York$2.9M
- Jonathan VigdorchikNew York$2.3M
- William LongNew York$1.5M
- Peter SculcoNew York$1.5M
- Roshan ShahNew York$1.3M
- Herbert CooperNew York$1.3M
- Matthew AustinNew York$986K
- Patrick MeereNew York$191K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.